Oil continued its climb to past highs on Tuesday amid reports that OPEC+ members are eyeing extensions to record production cuts. Major producer...
in May and June. The move brought must-needed relief to the market recently beset with flooded inventory and plummeting prices.
Crude prices remain well below the levels they enjoyed before Saudi Arabia and Russia kicked off a price war on March 6. While the two benchmarks have plenty of losses to retrace before a full rebound, both staged strong rallies through May as storage pressures eased and supply stabilized.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Putin and Trump Discussed OPEC+ Deal, Oil Market Recovery, Kremlin Says(Bloomberg) -- Russia’s President Vladimir Putin and his U.S. counterpart Donald Trump discussed the OPEC+ deal, just days before the producers’ alliance meets to discuss the future of its output cuts.“It has been stated that the multilateral agreement reached with active support of U.S. and Russian
Read more »
Oil prices edge up ahead of upcoming OPEC+ meetingOil prices were little changed on Monday, with the Organization of the Petroleum Exporting Countries (OPEC) considering meeting as soon as this week to discuss whether to extend record production cuts beyond end-June.
Read more »
Oil prices rise ahead of OPEC+ meeting on extended output cutsOil prices rose on Tuesday, with traders waiting to see whether major producers agree to extend their huge output cuts to shore up prices at a virtual meeting expected later this week.
Read more »
The Proposed Guidelines Disney World Will Follow Once the Park Reopens in JulyWhat Disney World could look like upon reopening in July, according to the guidelines set by the state for large theme parks, hotels, and restaurants.
Read more »
South Korea's Celltrion aims to start in-human COVID-19 drug trial in JulySouth Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.
Read more »